| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 30-Sep-04 | | Total Revenue | 64,946 | 58,416 | 58,913 | 30,704 | | Cost of Revenue | 28,055 | 27,284 | 26,250 | 17,592 | | | Gross Profit | 36,891 | 31,132 | 32,663 | 13,112 | | | Operating Expenses | | Research Development | 15,242 | 15,446 | 16,056 | 4,726 | | Selling General and Administrative | 9,840 | 10,305 | 11,455 | 4,182 | | Non Recurring | 1,647 | 1,394 | 1,017 | 3,298 | | Others |
-
|
-
|
-
| 11 | | | | Total Operating Expenses |
-
|
-
|
-
| 12,217 | | | | Operating Income or Loss | 10,162 | 3,987 | 4,135 | 895 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 202 | 325 | 214 | 387 | | Earnings Before Interest And Taxes | 10,364 | 4,312 | 4,349 | 1,282 | | Interest Expense | 185 | 256 | 294 | 547 | | Income Before Tax | 10,179 | 4,056 | 4,055 | 735 | | Income Tax Expense | 3,494 | 1,043 | 1,836 |
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,685 | 3,013 | 2,219 | 735 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,685 | 3,013 | 2,219 | 735 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,685 | $3,013 | $2,219 | $735 |
|
0.51% Nasdaq 
Income Statement
